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ABSTRACT 
Cancer that is benign is often known as a tumor. Currently cancer is a disease that causes death in the world. Cancer 
can attack all human organs including the nasopharynx. Nasopharyngeal cancer occupies the top 10 most cancers in 
Indonesia. Various methods have been used to treat cancer, one of which is radiotherapy. The dose of radiotherapy 
using a fractionated dose and a dose fraction for nasopharyngeal cancer of 1.6 Gy-2.2 Gy. The dosing must consider 
many things, such as the patient's condition, the duration of treatment and the dose of therapy. Due to the complexity 
of the metabolic processes of tumor cells, so far it has not been able to reveal the changes in detail. In this research, 
using mathematical modeling for clinical treatment including cancer treatment. In this study, the modeling used was 
Gompertz tumor growth and Linear Quadratic (LQ) radiotherapy model. Modeling uses the Rungge-Kutta Order 4 
method to solve differential equations and has a higher accuracy than the Heun method. The model was applied to 13 
clinical data of nasopharyngeal cancer patients. The results of this study indicate validation with a high level of 
accuracy using the analysis of the Root Mean Square Error (RMSE) and Mean Absolute Percentage Error (MAPE). 
RMSE and MAPE were best in 12 patients with values of 0.96 and 2.31%. All models of the 13 patients were consistent 
with clinical data. Therefore, this mathematical model can be used as a reference for radiotherapy planning models in 
hospitals. 
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1. INTRODUCTION 
Tumor is a general term for an abnormal lump in 
certain organs. Tumor cell growth occurs abnormally 
in the body, both those that are benign (benign) and 
those that are malignant (malignant). Cancer is a term 
for tumor cells that have malignant properties. Cancer 
cells grow rapidly and out of control. Some organs are 
susceptible to cancer [1]. Cancer is one of the leading 
diseases in the world. In 2018 there were 18.1 million 
new cancer cases and 9.6 million of which died from 
cancer occurred globally [2]. Based on preliminary 
data on cancer diagnosis in 2008-2014 based on Dr.. 
Sardjito hospital with the top 10 diagnoses of 
nasopharyngeal cancer ranks fourth with 745 cases 
[3]. Several treatment methods that can be used for 
cancer therapy are hormone therapy, surgery, 
immunotherapy, chemotherapy and radiotherapy. 
Radiotherapy or radiation therapy is a non-surgical 
therapy for curative treatment or cure of cancer. 
Approximately 50% required for radiotherapy 
annually worldwide are diagnosed with cancer [4]. 
Radiation therapy is administered according to a 
fractionated dose rule based on a radiobiological rule. 
Fractionation studies in radiotherapy began to be 
developed after it was realized that a single dose of 
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radiotherapy was ineffective for tumor control and had 
serious side effects [5]. However, not all fractionated 
doses provide maximum results. Apart from treating, 
radiation-exposed tissue has side effects, namely lethal 
damage (cell death), sublethal damage, and potentially 
lethal damage. It is also influenced by the overall 
treatment time and the delay in cell proliferation after 
irradiation [6].  
The complexity of the metabolic process of tumor 
cells has not been able to reveal the mechanism of 
change in detail. Therefore, researchers describe in 
mathematical modeling for clinical medicine 
including cancer treatment. Some researchers use 
mathematical models to describe tumor cell 
development. In previous research [7] through the 
Gompertz equation with the introduction of simple 
differential equations to describe the evolution of 
tumor cells from solid tumor cells. However, modeling 
in this study is limited to simulating the growth in 
tumor volume. 
Recently, many investigators have begun to study 
mathematical models of tumor response to radiation 
therapy [8] with simple mathematical models to 
simulate tumor volume growth and response to high 
dose single irradiation fractions. Models can be used 
to find biological parameters in treatment. However, 
there is too large a statistical uncertainty because the 
sample used is too small. Research was continued [9] 
to prepare a simple mathematical model of the 
distribution of tumor cells in fractional tumor 
radiotherapy with computer simulations. The tumor 
growth model of three cell components in the tumor, 
namely, dividing cells, non-dividing cells and 
quiestient cells. The Gompertz tumor model was 
formulated and applied to fractional radiotherapy with 
a set of precise parameters. However, the parameters 
used are limited to the general case assumption of 
tumor radiotherapy. So, when faced with a particular 
organ case, further research is needed. 
The complexity of biomedical activities and the 
limitations of the research conditions have resulted in 
some of the above research models only being used for 
general tumor growth analysis. In addition, tumor cells 
also experience interactions with radiation particles in 
radiotherapy. Modeling and simulation are expected to 
be able to present an overview of the effect of radiation 
on tumor cell volume. So that it can be seen the length 
of therapy and the amount of dose required in 
radiotherapy to get the tumor cell volume decreases 
until the cells die. So, it is necessary to do research 
"Modeling and Simulation of the Effect of 
Radiotherapy on Nasopharyngeal Tumor Volume with 
the Rungge-Kutta Method of 4 Order ". The Runge-
Kutta method is one of the most popular methods of 
solving differential equations. Especially the Runge-
Kutta Method 4 Order which is often used in 
numerical calculations. The higher accuracy is the 
advantage of this method compared to the Euler 
method and the Heun method [10]. Modeling and 
simulation in this study are expected to determine and 
describe the effect of radiation dose on radiotherapy 
volume of nasopharyngeal tumor cells. 
1.1. Cancer 
Tumor is a general term for an abnormal lump in 
certain organs. Abnormal tumor cell growth in the 
body, both benign (benign) and malignant (malignant) 
[1]. Cancer cells continue to divide and do not 
maintain normal growth laws. Cancer can attack 
various tissues in organs, such as skin cells, liver cells, 
blood cells, brain cells, breast cells, lung cells, urinary 
tract cells, and various other body cells. Cancer occurs 
when cells in a part of the body start to grow and get 
out of control. This occurs when the DNA is damaged 
beyond repair [11]. 
1.1.1. Nasopharyngeal Cancer 
Nasopharyngeal cancer grows in the cavity 
behind the nose and behind the roof of the mouth. Like 
other cancers, the cause of nasopharyngeal cancer is 
not certain. However, the onset of nasopharyngeal 
cancer is closely related to the epstein bar virus (herpes 
virus) [12]. Nasopharyngeal cancer is a malignant 
tumor of the nasopharyngeal epithelium. The disease 
was originally reported in 1901 and clinically 
characterized in 1922. Nasopharyngeal cancer is a 
disease with a worldwide geographical and racial 
distribution. It is a rare malignancy with an incidence 
of under 1 / 100,000 population per year in Caucasians 
of North America and other Western countries. The 
highest incidence was recorded in the Southern 
Chinese Population of Guangdong, the incidence was 
15-25 cases per 100,000. NPC is also called "Canton 
tumor" in Guangdong Province [8]. 
1.2. Define Target Volume 
Target Volume definition is a prerequisite for 3-D 
care for accurate dose planning and reporting. 
International Commission of Radiation Units and 
Measurement (ICRU) Report No. 50 and 62 define and 
describe some critical target and volume structures 
that aid in the care planning process. The following 




volumes have been defined as the main volumes 
associated with 3-D treatment planning [13]: 
a. Gross Tumor Volume (GTV) 
GTV is the volume of the tumor that can be felt or 
seen the level and location of the malignant growth 
that is proven. GTV is usually based on information 
obtained from a combination of imaging modalities 
(computed tomography (CT), magnetic resonance 
imaging (MRI), ultrasound, etc.), diagnostic 
modalities (pathology and histology, reports, etc.) and 
clinical examination. 
b. Clinical Target Volume (CTV) 
CTV is a tissue volume containing GTV and / or 
subclinical microscopic malignant disease, which 
must be removed. This volume must be treated 
adequately to achieve therapeutic, healing or palliative 
goals. CTV often covers the area around GTV, which 
may contain microscopic disease and other areas that 
are considered risky and need treatment (for example, 
positive lymph nodes). 
c. Internal Target Volume (ITV) 
ITV consists of CTV plus internal margins. 
Internal margins are designed to account for variations 
in the size and position of the CTV relative to the 
patient's reference frame (usually determined by bone 
anatomy); that is, variations due to movement of 
organs such as breathing and bladder or rectal 
contents. 
d. Planning Target Volume (PTV) 
PTV is a geometric concept, for selecting the right 
setting and ensuring that the specified dose is 
completely absorbed in the CTV. PTV includes 
internal target margins and additional margins for 
regulatory uncertainty, tool tolerances, and variation 
outside of therapy. The PTV is linked to the processing 
machine's reference frame and is often described as 
CTV plus a fixed or variable margin (eg PTV = CTV 
+ 1 cm). 
e. Organ at Risk (OAR) 
Organs at risk are organs that are sensitive to 
radiation so the dose received from the treatment plan 
may be more significant than its tolerance, requiring a 
change in radiation setting or a change in dose. 
Particular attention should be paid to organs that, 
although not directly adjacent to CTV, have very low 
dose tolerance (eg, the lens of the eye during treatment 
of the nasopharynx or brain tumors). 
1.3. Radiotherapy 
Radiation is one of the main cancer treatment 
options for the neck and head, glands, lungs and 
Hodgkin's disease. However, radiation can also be 
given to other types of cancer. Radiation therapy can 
be done either alone or in combination with surgery or 
chemotherapy. Therapy which has a local effect can be 
given internally or externally. Internally, namely in the 
form of radioactive implants that are inserted in the 
cancer area. Meanwhile, external therapy is by firing 
radioactive waves at cancer cells [11]. 
The goal of radiotherapy in general is palliative 
and radical treatment. Palliative treatment is applied to 
cases of advanced cancer to relieve symptoms, 
because it is inoperable and is given in a short period 
of 1-2 weeks. Meanwhile, radical treatment or primary 
therapy to shrink the tumor followed by surgery at 
longer intervals of 4-6 weeks [14]. 
Ionizing radiation consisting of electromagnetic 
radiation, or photons, is the type of radiation most 
commonly used to treat patients with radiotherapy. 
The damaging effects of this type of radiation arise 
from their ability to ionize, or remove electrons, from 
molecules in cells. Nearly all photons are produced by 
linear accelerators which have sufficient ionization 
energy. Most of the biological damage is done by the 
ejected electrons which in turn causes further 
ionization of the molecule which collides and slows 
down further. At the end of the electron trajectory, 
interactions with other molecules become more 
frequent, giving rise to ionization groups. Ionization 
can occur in several DNA base pairs [15]. 
2. MATERIALS AND METHODS 
2.1. Research Materials 
The equipment and materials used in this study 
are: 
1. Notebook 
2. MATLAB software version 2008b 
3. Microsoft office Excel 2016 software 
4. Examination data of nasopharyngeal cancer patients 
before and during the review of 13 patients with 
nasopharyngeal tumor radiotherapy at Shandong 
Cancer Hospital from January 2014-April 2015 [16]. 





2.2.1. Tumor Growth Model 
The tumor growth model solves the problem of 
describing radiation-induced tumor growth and 
metabolism so that it can be used to improve the 
optimization of radiotherapy. The tumor growth model 




= 𝑓(𝑁)      (1) 
      
where N is the clogenic number of tumor cells or cells 
that proliferate i.e. the tumor volume in time t and f 
(N) is an appropriate function. Exponential growth is 
described by the differential equation [18]: 
𝑑𝑉(𝑡)
𝑑𝑡
= 𝑟𝑉(𝑡)    (2) 
      
where, the rate of increase in volume dV against dt 
with volume V (t) times the growth rate r which is 
assumed to be constant. Tumor interactions that occur 
with inhibitors and cell nutrition in the body. Both 
explain dynamic tumor development. These ideas 
generally include the logistical equation [19]: 
𝑉′ = 𝑃𝑉      (3) 
where,  





)   (4) 
   
V  is the rate of tumor change for the decrease 
in factor P from tumor volume V in the slowing down 
of tumor growth to Vmax which limits when the tumor 
grows and the tumor carrying capacity or available 
capacity. The breakdown of the combined deceleration 
α = 0 and approaches the limit in the form of Gompertz 
[19]: 
𝑃 = − 𝜆𝛼 log (
𝑉
𝑉𝑚𝑎𝑥
)      (5)  
Tumor growth in the Gompertz equation acts 
as a two-way control process in which the tumor 
regulates growth or vascular suppression, and tumor 
blood vessels control tumor growth through nutritional 
function. Historically, the value of Vmax in equation 
(8) is the level of carrying capacity for the tumor or K 
(t) then [19], 
𝑃 = − 𝜆𝛼 log (
𝑉
𝐾
)    (6) 
Equation (6) becomes: 
𝑉′ = − 𝜆𝑉 log (
𝑉
𝐾
)    (7) 
or: 
𝑉′ = 𝜆𝑉 log (
𝐾
𝑉
)     (8) 
Exponential growth kinetics can describe tumor 
growth well. To account for the dynamically 
decreasing tumor growth rate in the Gompertz 
equation. Where the evolution of the number of N 
tumor cells in volume with the growth rate ρ = λ is 
described by the following differential equation [20]: 
𝑑𝑁
𝑑𝑡
=  ρ N (t) log (
𝐾
𝑁(𝑡)
)  (9) 
Growth rate ρ and carrying capacity K are defined as 
the effective vascular support provided for the tumor 
as reflected by the size of the potentially sustainable 
tumor. With these equations, one Gompertz growth 
curve can be simulated for different initial tumor 
volumes and it is possible to describe clinical stages I 
to IV in one framework. 
2.2.2. Radiotherapy Model 
The quadratic linear model has two main 
components, the first is the linear component. The 
linear component is described as a straight line / 
arithmetic, which indicates that cell death is directly 
proportional to dose (αd). Another component 
illustrates that cell death is directly proportional to the 
square of the dose (βd2), which is called the quadratic 
component. Basic quadratic linear formula [21]: 
𝐸 = 𝐷(𝛼 + 𝛽𝑑)   (10) 
Where E is the radiation effect received by each 
fraction of the surviving cells. The total dose is D (n × 
d) and d is the dose every n fraction. Then to assume 
the fraction of cells that survive [21], 
𝑆 = 𝑒−𝐸    (11) 
Then equations (10) and (11) become, 
𝑆 = 𝑒−𝑛(𝛼𝑑+𝛽𝑑
2)   (12) 
or, 
𝑆 = 𝑒−(𝛼𝐷+𝛽𝐷
2)   (13) 
when described against (t) then, 
 






= −(𝛼𝐷 + 𝛽𝐷2)𝑑𝑡   (14) 
The LQ model describes the cells that survive being 
irradiated with a radiation dose. This equation can be 
described in the differential equation [21]: 
𝑑𝑁(𝑡)
𝑑𝑡
= −(𝛼𝑑(𝑡) + 𝛽𝑑(𝑡)2)𝑁(𝑡)  (15) 
In the radiotherapy model approach, the α / β 
constant is assumed to be ± 10 Gy and d is the dose per 
fraction. Radiation-induced cell killing is determined 
by the patient's radiosity parameter which refers to the 
susceptibility of cells to the effects of radiation. There 
is a negative symbol on radiotherapy indicating a 
reduction in tumor growth due to the radiotherapy 
constant. The two models were combined into a 
differential formula to model the patient's tumor 
growth during radiotherapy treatment. 
𝑑𝑁(𝑡)
𝑑𝑡
=  ρ N (t) log (
𝐾
𝑁(𝑡)
) − (𝛼𝑑(𝑡) + 𝛽𝑑(𝑡)2)𝑁(𝑡)  
     (16) 
The constant ρ has a value of 7 × 10-3 with K = 30, 
for α and β obtained through the estimation of Particle 
Swarm Optimization (PSO) programming, which is a 
population-based algorithm for the exploitation of 
individuals in search. Repetition of α and β on the PSO 
by providing the minimum and maximum ranges so 
that an accuracy of> 90% is achieved. The α and β 
constants that reach the best accuracy will be 
simulated by equation (19) with the 4th order Runge-
Kutta method. 
3. RESULTS AND DISCUSSION 
3.1 Model Validation 
The accuracy of the model with experimental data 
can be interpreted by the value of Root Mean Square 
(RMSE) and Mean Absolute Precentage Error 
(MAPE). The smaller the RMSE (close to 0) the 
RMSE value, the more accurate the prediction results 
will be (Suprayogi., Et al. 2014). Meanwhile, the 
MAPE percentage shows the best model validation 
[22]. 
Validation ith RMSE and MAPE was carried out 
in the last part of the simulation for the evaluation of 
the volume model shown in tables 4.3 and 4.5 with the 
best RMSE and MAPE criteria in patient 12, namely 
0.96 and 2.31%. Patient 5 showed the greatest criteria 
for MRSE and MAPE values, namely 3.34 and 
25.74%. The duration of treatment in the experiment 
lasted 5 days each week for 30 days. The model 
validation adjusted the duration and dose fraction of 
2.2 Gy in experimental radiotherapy, namely the initial 
radiotherapy, days 1, 6, 11, 16, 21 and 26. 
 
Table 1. Simulation Constants 
Constants Information Value Unit Reference 
Constants Information Value Unit Reference 
𝑁 Tumor volume Input cm3 Gai.,dkk, 2017 
Ρ 
Growth parameters (Growth rate 
which refers to changes in certain 
variables) 7×10-3 1 Geng, 2017 
𝐾 
Tumor carrying capacity or 
available capacity 30 cm3 Geng, 2017 
𝛼/𝛽 
Quadratic linear component 
(describing cell death as directly 
proportional to dose) 10 Gy Joiner, 2009 
𝑑 
Dosage per fraction (daily dose 
given during therapy) Input Gy KEMENKES, 2017 
T Time Input Day KEMENKES, 2017 
 




The best model validation and experimentation are 
in Figures 1. The average patient had a significant 
volume reduction in the late stages of treatment. The 
difference in decrease was due to the initial volume 
and different α and β values in each patient. This 
shows the level of diversity in the cell sensitivity of 
each patient to the radiation dose received. 
Treatment of tumors and cancer with 
radiotherapy has the principle of killing or reducing 
cancer tissue optimally and not destroying normal 
tissue around cancer cells. The existence of simulation 
and modeling is able to provide the best for planning 
and optimization during radiotherapy. The dosage and 
duration used in radiotherapy are according to the 
degree of susceptibility of nearby organs to the tumor 
tissue and the condition of the tumor tissue. In this 
study, the patient with the greatest volume reduction 
and the fastest duration was in patient 3 with the best 
dose fraction of 2.2 Gy and the volume at week 6 was 
5.33 cm3. Conversely, for the smallest volume 
reduction with a long duration, patient 12 had the best 
dose of 2.2 Gy and the volume at week 6 was 30.22 
cm3. 
According to the Ministry of Health [23] 
definitive dose of curative radiotherapy without 
chemotherapy for high risk (primary tumor and 
positive lymph nodes, including possible subclinical 
infiltration of primary tumors and high risk lymph 
nodes): 66 Gy (2.2 Gy / fraction) to 70 Gy (1 , 8-2 Gy 
/ fraction). Whereas for low to medium risk (locations 
where subclinical spread is suspected): 44-50 Gy (2 
Gy / fraction) to 54-63 Gy (1.6-1.8 Gy / fraction). All 
therapy are given 5 days a week for both primary and 
glandular tumors for 6-7 weeks. 
The dose of radiotherapy is given gradually in 
fractions. The greater the dose given, the tumor 
shrinks rapidly. However, the dose of radiotherapy is 
not given directly in large quantities. According to 
Beyzadeoglu et al. [5] single dose radiotherapy is not 
effective for tumor control and has serious side effects, 
so fractionated doses of radiotherapy are applied. This 
study used hypofraction, which is a fraction dose> 2 
Gy with the number of fractions per day ≤ 1, the 
number of fractions per week ≤ 5, the number of 
fractions per treatment ≤ 25-35, and the total dose <45-
70 Gy. The purpose of hypofraction is generally used 
for palliative purposes in the management of 
metastatic tumors. 
According to Chua [24] in his study showed that 
the fractionation dose was superior to a single dose in  
  
Table 2. Results of the validation of the patients model 1-7 
Constants 
Patients 
















3.34 2.22 1.88 
 
MAPE (%) 
7.58 22.85 18.34 11.35 25.74 23.58 20.76 
 
 
Table 3. Results of the validation of the patients model 8-13 
Constants 
Patients 


























RMSE 2.01 1.75 1.87 1.97 0.96 3.77 2.01 




2.31 10.22 23.22 
 





Figure 1 Simulation of Patients 10-13 Model (Solid Line) and Clinical Data (Blue Circle). 
saving the local failure of nasopharyngeal carcinoma, 
especially in the treatment of recurrent and all-stage 
 disease. Records of 125 NPC patients who 
received median radiation dose were 12.5 Gy in single 
fraction and 34 Gy in 2-6 fractionation. The incidence 
of severe advanced complications was 33% at single 
dose and 21% at fractionated dose, including brain 
necrosis (16% and 12%) and bleeding (5% and 2%). 
According to Hasan [25] radiation in biological 
networks is divided into three phases, namely the 
phases of physics, chemistry and biology. Photon 
ionizing radiation that hits biological tissue, initially 
causes a physical phase by ionization and excitation 
methods. Furthermore, a chemical phase occurs with 
the formation of free radicals. Free radicals that are 
formed cause biological damage by damaging DNA. 
Irreparable DNA damage will lead to cell death. 
4. CONCLUSION 
`Mathematical models of tumor growth and 
radiotherapy models using the Runge Kutta Order 4 
method have different accuracy. The best accuracy is 
the best RMSE and MAPE in patient 12, namely 0.96 
and 2.31%. Patient 5 showed the greatest criteria for 
MRSE and MAPE values, namely 3.34 and 25.74%. 
The duration of treatment in the experiment lasted 5 
days each week for 30 days. The accuracy of all 
patients occupies sufficient criteria. The suitability of 
the model and experiment for each patient is different, 
this is due to various influencing factors. The biggest 
effect of the α and β values, the smaller the accuracy 
value which indicates the better the criteria for the best 
model. 
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